420 related articles for article (PubMed ID: 28538441)
1. Hyperlactatemia, Lactate Kinetics and Prediction of Citrate Accumulation in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation.
Khadzhynov D; Dahlinger A; Schelter C; Peters H; Kindgen-Milles D; Budde K; Lehner LJ; Halleck F; Staeck O; Slowinski T
Crit Care Med; 2017 Sep; 45(9):e941-e946. PubMed ID: 28538441
[TBL] [Abstract][Full Text] [Related]
2. Hyperlactatemia Predicts Citrate Intolerance With Regional Citrate Anticoagulation During Continuous Renal Replacement Therapy.
Tan JN; Haroon SWP; Mukhopadhyay A; Lau T; Murali TM; Phua J; Tan ZY; Lee N; Chua HR
J Intensive Care Med; 2019 May; 34(5):418-425. PubMed ID: 28372501
[TBL] [Abstract][Full Text] [Related]
3. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
4. Severe hyperlactatemia, lactate clearance and mortality in unselected critically ill patients.
Haas SA; Lange T; Saugel B; Petzoldt M; Fuhrmann V; Metschke M; Kluge S
Intensive Care Med; 2016 Feb; 42(2):202-10. PubMed ID: 26556617
[TBL] [Abstract][Full Text] [Related]
5. Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience.
Sponholz C; Settmacher U; Bauer M; Kortgen A
Ther Apher Dial; 2015 Feb; 19(1):8-15. PubMed ID: 25196675
[TBL] [Abstract][Full Text] [Related]
6. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
Finkel KW; Foringer JR
Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
[TBL] [Abstract][Full Text] [Related]
7. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
[TBL] [Abstract][Full Text] [Related]
8. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
[TBL] [Abstract][Full Text] [Related]
9. Hyperlactatemia in ICU patients: Incidence, causes and associated mortality.
Ferreruela M; Raurich JM; Ayestarán I; Llompart-Pou JA
J Crit Care; 2017 Dec; 42():200-205. PubMed ID: 28772222
[TBL] [Abstract][Full Text] [Related]
10. Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients.
Jeyaraju M; McCurdy MT; Levine AR; Devarajan P; Mazzeffi MA; Mullins KE; Reif M; Yim DN; Parrino C; Lankford AS; Chow JH
Crit Care Med; 2022 Jan; 50(1):50-60. PubMed ID: 34166293
[TBL] [Abstract][Full Text] [Related]
11. Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.
Klingele M; Stadler T; Fliser D; Speer T; Groesdonk HV; Raddatz A
Crit Care; 2017 Nov; 21(1):294. PubMed ID: 29187232
[TBL] [Abstract][Full Text] [Related]
12. Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study.
Schultheiß C; Saugel B; Phillip V; Thies P; Noe S; Mayr U; Haller B; Einwächter H; Schmid RM; Huber W
Crit Care; 2012 Aug; 16(4):R162. PubMed ID: 22913794
[TBL] [Abstract][Full Text] [Related]
13. [Effect of lactic acid levels on the prognosis of critically ill patients after cardiac and non-cardiac surgery: an analysis of 549 cases].
Sun R; Chao K; Yang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Feb; 30(2):123-127. PubMed ID: 29402360
[TBL] [Abstract][Full Text] [Related]
14. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill children.
Sık G; Demirbuga A; Annayev A; Citak A
Int J Artif Organs; 2020 Apr; 43(4):234-241. PubMed ID: 31856634
[TBL] [Abstract][Full Text] [Related]
15. Continuous hemodialysis with citrate anticoagulation and standard dialysate for managing acute kidney injury in patients with moderate to severe hyponatremia-A retrospective study.
Hellman T; Uusalo P; Järvisalo MJ
Acta Anaesthesiol Scand; 2021 Jul; 65(6):778-784. PubMed ID: 33595109
[TBL] [Abstract][Full Text] [Related]
16. Heparin-Free Prolonged Intermittent Hemodialysis Using Calcium-Free Citrate Dialysate in Critically Ill Patients.
Faguer S; Saint-Cricq M; Nogier MB; Labadens I; Lavayssiere L; Kamar N; Cointault O
Crit Care Med; 2017 Nov; 45(11):1887-1892. PubMed ID: 28857854
[TBL] [Abstract][Full Text] [Related]
17. Regional citrate anticoagulation versus low molecular weight heparin for CRRT in hyperlactatemia patients: A retrospective case-control study.
Li L; Bai M; Zhang W; Zhao L; Yu Y; Sun S
Int J Artif Organs; 2022 Apr; 45(4):343-350. PubMed ID: 33784842
[TBL] [Abstract][Full Text] [Related]
18. [The safety and efficacy of regional citrate anticoagulation in sustained low efficiency dialysis].
Zhang L; Wang TL; Zhao YL; Chen ZW; Tang Y; Yang YY; Liao YJ; Fu P
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):459-63. PubMed ID: 24059990
[TBL] [Abstract][Full Text] [Related]
19. Blood Lactate Levels Cutoff and Mortality Prediction in Sepsis-Time for a Reappraisal? a Retrospective Cohort Study.
Filho RR; Rocha LL; Corrêa TD; Pessoa CM; Colombo G; Assuncao MS
Shock; 2016 Nov; 46(5):480-485. PubMed ID: 27380535
[TBL] [Abstract][Full Text] [Related]
20. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
Davis TK; Neumayr T; Geile K; Doctor A; Hmeil P
Pediatr Crit Care Med; 2014 Jun; 15(5):471-85. PubMed ID: 24777299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
